Impact of the COVID-19 pandemic on Neonatal Screening for Congenital Hypothyroidism
e202012176
Keywords:
Congenital Hypothyroidism, COVID-19, Neonatal screeningAbstract
Background: The purpose of this paper was to describe the diagnosis, treatment and follow-up of patients diagnosed with congenital hypothyroidism (CH) by the Neonatal Screening Program in the Autonomous Community of Madrid during the state of alarm due to the COVID-19 health crisis.
Methods: The data were extracted from the retrospective analysis of patients diagnosed with CH and treated at the Clinical Diagnosis and Follow-up Center of CH located in the Pediatric Endocrinology Unit of the General University Hospital Gregorio Marañon.
Results: During the period between March 14 and June 21, 2020, 7 neonates were diagnosed with congenital hypothyroidism. The Screening Center contacted the Clinical Diagnosis and Follow-up Center urgently, with the location and clinical assessment of the patient on the same day, performing the usual complementary examinations in all of them according to clinical pathway. The median age of diagnosis was 15.5 days (range 7.00-24.00). The subsequent clinical and analytical follow-up was carried out in all cases according to the recommended times. All patients presented normalization of the thyroid function after two weeks of treatment.
Conclusions: All patients seen at the Congenital Hypothyroidism Clinical Diagnosis and Follow-up Center during the alarm state period were diagnosed, treated and reevaluated following the usual clinical pathways without incidents. The current epidemiological situation of the COVID-19 pandemic has revealed the correct functioning of the circuit of the Congenital Hypothyroidism Screening Program in less favorable circumstances.
Downloads
References
Rodríguez Sánchez, A, Huidobro Fernández B, Dulín Íñiguez E, Rodríguez Arnao MD. Seguimiento del niño con hipotiroidismo congénito. Rev Esp Endocrinol Pediatr. 2014; Volumen 5. Suplemento 2.
Haddow JE, Palomaki GE, Allan WC et al. Maternal thyroid during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999; 341:549 –555.
Léger J, Olivieri A, Donaldson M et al. European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism. J Clin Endocrinol Metab. 2014; 99(2):363-84.
Rastogi MV, LaFranchi SH. Congenital hypothyroidism. Orphanet J Rare Dis. 2010; 5:17.
Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28(2):175-187.
Mayayo Dehesa E, Santisteban Sanz P, Labarta Aizpún JI, Ferrández Longás A. Hipotiroidismo Congénito. En: Tratado de Endocrinología Pediátrica (4ª ed.). Eds.: M. Pombo y cols. McGraw-Hill/Interamericana. Madrid, 2009. Cap.31:367-385.
Rodríguez Arnao MD, Rodríguez Sánchez A. Hipotiroidismo congénito y neonatal. En: Endocrinología (2ª Ed.) A. Jara (Ed.). Editorial Médica Panamericana, Madrid. Capítulo 19. Págs. 185-199.
Rodríguez Sánchez A, Huidobro Fernández B, Rodríguez Arnao MD. Hipotiroidismo congénito y neonatal. Pediatr Integral. 2011; 15:643- 653.
Rodríguez Sánchez A; Chueca Guindulain MJ, Alija Merillas M, Ares Segura S, Moreno Navarro J, Rodríguez Arnao MD. Diagnóstico y seguimiento de los pacientes con hipotiroidismo congénito diagnosticados por cribado neonatal. Anales de Pediatría. Volume 90, Isssue 4, Abril 2019; 250.e1-250.e8.
Sanz Fernández M, González Ruiz de León E, Rodríguez Sanchez A, Patología del tiroidea en el niño y adolescente. Pediat Integral. 2015; XIX (7), 667-476.
Foley T, Kaplowitz PB, Kaye CI, Sundararajan S, Varma SK. American Academy of Pediatrics. Rose SR. Section on Endocrinology and Committee on Genetics ATABRPHC Lawson Wilkins Pediatric Endocrine Society: Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics. 2006; 117(6): 2290-2303.
Couce ML. Fifty years of neonatal screening for congenital diseases in Spain. Anales de Pediatría (English Edition). 2019 Volume 90, Issue 4: April 2019.p 205-206.
Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SM. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr. 2000; 136:292–297.
LaFranchi SH, Austin J. How should we be treating children with congenital hypothyroidism. J Pediatr Endocrinol. 2007; 20 (5): 559-578.
Oliveiri A, Stazi Ma, Mastroiacovo P, Fazzini C, Medda E, Spagnolo A, De Angelis S, Grandolfo ME, Taruscio D, Cordeddu V et al. A population –based study on frecuncy of additonal congenital malformations in infants with congenital hypothyroidism: data from the italian Registry for Congenital Hypotiroidismo (1991-1991). J Clinc Endocrinol Metab. 2002, 87 (2); 557-562
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Marina Mora Sitja, María Sanz Fernández, Lucía Carrascón González-Pinto, Amparo Rodríguez Sánchez
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
